The cash flow of MURPHY USA INC. over the past 10 years
Chart MURPHY USA INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, MURPHY USA INC.'s operating cash flow was $813.9M and its capital expenditures $439.6M, leaving free cash flow of $374.3M. Free cash flow was above zero in all 10 years shown. It ranged from $25.3M in fiscal 2017 to $689.4M in fiscal 2022. Capital expenditures were highest in fiscal 2024, at $458.1M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $813.9M | $439.6M | $374.3M |
| 2024ended Dec 31, 2024 | $847.6M | $458.1M | $389.5M |
| 2023ended Dec 31, 2023 | $784M | $335.6M | $448.4M |
| 2022ended Dec 31, 2022 | $994.7M | $305.3M | $689.4M |
| 2021ended Dec 31, 2021 | $737.4M | $274.7M | $462.7M |
| 2020ended Dec 31, 2020 | $563.7M | $230.7M | $333M |
| 2019ended Dec 31, 2019 | $313.3M | $204.8M | $108.5M |
| 2018ended Dec 31, 2018 | $398.7M | $204.3M | $194.4M |
| 2017ended Dec 31, 2017 | $283.6M | $258.3M | $25.3M |
| 2016ended Dec 31, 2016 | $337.4M | $262.1M | $75.3M |
Fiscal years as MURPHY USA INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MURPHY USA INC.
- The revenue of MURPHY USA INC.
- The profitability of MURPHY USA INC.
- The debt of MURPHY USA INC.
- The dividends of MURPHY USA INC.
- All of MURPHY USA INC.'s financials, charted
Companies of a similar size
- BXPBXP, INC.
- RRXREGAL REXNORD CORP
- BIOBIO-RAD LABORATORIES, INC.
- PTGXProtagonist Therapeutics, Inc
- AYIACUITY INC
Not investment advice. This page shows what MURPHY USA INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.